US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

5.420
+0.115+2.17%

Close Jul 22 16:00 ET

5.480
+0.060+1.11%

Post 19:47 ET

650.57MMarket Cap-2486P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-62.91%-67.71M

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

-213.33%-30.1M

-20.22M

Net income from continuing operations

-16.15%-45.76M

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

---29.35M

Operating gains losses

----

250.00%28K

----

--8K

--0

----

Depreciation and amortization

25.00%1.32M

109.22%4.65M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

291.55%2.22M

279.91%870K

277.84%631K

--430K

Deferred tax

166.34%134K

71.06%-279K

--0

-150.94%-108K

107.01%31K

62.03%-202K

-54.49%-964K

-116.25%-202K

108.95%212K

---442K

Other non cash items

18.26%3.35M

30.62%12.79M

19.66%3.35M

13.21%3.14M

41.93%3.47M

59.49%2.83M

-89.94%9.79M

-96.81%2.8M

103.79%2.77M

--2.45M

Change In working capital

-249.48%-30.11M

107.48%2.65M

1,133.99%14.45M

162.34%2.4M

-456.70%-5.59M

74.87%-8.62M

-213.55%-35.4M

-96.29%1.17M

-393.33%-3.85M

--1.57M

-Change in prepaid assets

-117.43%-2.79M

-444.02%-9.46M

36.93%-415K

-260.75%-3.74M

-1,098.21%-4.01M

-540.07%-1.29M

-96.38%-1.74M

-170.78%-658K

-171.47%-1.04M

---335K

-Change in payables and accrued expense

-424.29%-23.86M

204.20%24.4M

304.78%18.29M

1,625.97%8.44M

-42.46%2.22M

85.90%-4.55M

-164.34%-23.42M

-86.47%4.52M

-25.46%489K

--3.85M

-Change in other current liabilities

-24.49%-3.46M

-19.98%-12.3M

-27.40%-3.43M

30.30%-2.3M

-94.26%-3.79M

-20.49%-2.78M

-136.67%-10.25M

-69.61%-2.69M

-213.09%-3.3M

---1.95M

Cash from discontinued investing activities

Operating cash flow

-62.91%-67.71M

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

-213.33%-30.1M

---20.22M

Investing cash flow

Cash flow from continuing investing activities

-192.40%-37.03M

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

-76.94%-13.51M

-50.79M

Net PPE purchase and sale

-16.26%-2.32M

45.80%-8.72M

61.78%-1.84M

39.28%-2.91M

58.85%-1.98M

-18.42%-2M

-287.83%-16.1M

-1,160.21%-4.81M

-162.66%-4.79M

---4.8M

Net investment purchase and sale

-225.41%-34.71M

191.00%27.61M

586.08%43.13M

-299.78%-34.86M

166.32%30.01M

-132.82%-10.67M

56.02%-30.34M

-168.98%-8.87M

-47.30%-8.72M

---45.24M

Net other investing changes

----

74.44%-170K

--0

----

-34.07%-665K

99.69%-1K

--0

---745K

Cash from discontinued investing activities

Investing cash flow

-192.40%-37.03M

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

-76.94%-13.51M

---50.79M

Financing cash flow

Cash flow from continuing financing activities

231,263.24%157.33M

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

-68,200.00%-683K

-624K

Net common stock issuance

--132.06M

--0

----

--0

--185.32M

----

Proceeds from stock option exercised by employees

28,241.18%19.27M

199.09%655K

24.36%194K

404.76%318K

--75K

--68K

--219K

--156K

--63K

--0

Net other financing activities

--6M

----

-272.19%-4.04M

---1.4M

---746K

---624K

Cash from discontinued financing activities

Financing cash flow

231,263.24%157.33M

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

-68,200.00%-683K

---624K

Net cash flow

Beginning cash position

-72.62%55.07M

1.29%201.12M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

436.97%198.55M

-69.38%61.44M

-51.48%105.74M

--177.37M

Current changes in cash

197.10%52.59M

-5,780.51%-146.05M

-101.71%-2.39M

-72.98%-76.62M

82.01%-12.89M

-155.80%-54.16M

-98.41%2.57M

6,691.46%139.67M

-156.87%-44.29M

---71.64M

End cash Position

-26.74%107.66M

-72.62%55.07M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

-69.38%61.44M

--105.74M

Free cash flow

-60.77%-70.03M

-17.72%-174.14M

-28.65%-45.7M

-20.60%-42.08M

-71.02%-42.8M

17.00%-43.56M

-286.91%-147.92M

-161.82%-35.53M

-205.24%-34.89M

---25.03M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-62.91%-67.71M	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M	-213.33%-30.1M	-20.22M
Net income from continuing operations	-16.15%-45.76M	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M	---29.35M
Operating gains losses	----	250.00%28K	----	----	----	----	--8K	--0	----	----
Depreciation and amortization	25.00%1.32M	109.22%4.65M	43.33%1.25M	95.88%1.24M	160.00%1.12M	259.04%1.05M	291.55%2.22M	279.91%870K	277.84%631K	--430K
Deferred tax	166.34%134K	71.06%-279K	--0	-150.94%-108K	107.01%31K	62.03%-202K	-54.49%-964K	-116.25%-202K	108.95%212K	---442K
Other non cash items	18.26%3.35M	30.62%12.79M	19.66%3.35M	13.21%3.14M	41.93%3.47M	59.49%2.83M	-89.94%9.79M	-96.81%2.8M	103.79%2.77M	--2.45M
Change In working capital	-249.48%-30.11M	107.48%2.65M	1,133.99%14.45M	162.34%2.4M	-456.70%-5.59M	74.87%-8.62M	-213.55%-35.4M	-96.29%1.17M	-393.33%-3.85M	--1.57M
-Change in prepaid assets	-117.43%-2.79M	-444.02%-9.46M	36.93%-415K	-260.75%-3.74M	-1,098.21%-4.01M	-540.07%-1.29M	-96.38%-1.74M	-170.78%-658K	-171.47%-1.04M	---335K
-Change in payables and accrued expense	-424.29%-23.86M	204.20%24.4M	304.78%18.29M	1,625.97%8.44M	-42.46%2.22M	85.90%-4.55M	-164.34%-23.42M	-86.47%4.52M	-25.46%489K	--3.85M
-Change in other current liabilities	-24.49%-3.46M	-19.98%-12.3M	-27.40%-3.43M	30.30%-2.3M	-94.26%-3.79M	-20.49%-2.78M	-136.67%-10.25M	-69.61%-2.69M	-213.09%-3.3M	---1.95M
Cash from discontinued investing activities
Operating cash flow	-62.91%-67.71M	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M	-213.33%-30.1M	---20.22M
Investing cash flow
Cash flow from continuing investing activities	-192.40%-37.03M	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M	-76.94%-13.51M	-50.79M
Net PPE purchase and sale	-16.26%-2.32M	45.80%-8.72M	61.78%-1.84M	39.28%-2.91M	58.85%-1.98M	-18.42%-2M	-287.83%-16.1M	-1,160.21%-4.81M	-162.66%-4.79M	---4.8M
Net investment purchase and sale	-225.41%-34.71M	191.00%27.61M	586.08%43.13M	-299.78%-34.86M	166.32%30.01M	-132.82%-10.67M	56.02%-30.34M	-168.98%-8.87M	-47.30%-8.72M	---45.24M
Net other investing changes	----	74.44%-170K	--0	--0	----	----	-34.07%-665K	99.69%-1K	--0	---745K
Cash from discontinued investing activities
Investing cash flow	-192.40%-37.03M	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M	-76.94%-13.51M	---50.79M
Financing cash flow
Cash flow from continuing financing activities	231,263.24%157.33M	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M	-68,200.00%-683K	-624K
Net common stock issuance	--132.06M	--0	----	----	----	--0	--185.32M	----	----	----
Proceeds from stock option exercised by employees	28,241.18%19.27M	199.09%655K	24.36%194K	404.76%318K	--75K	--68K	--219K	--156K	--63K	--0
Net other financing activities	--6M	----	----	----	----	----	-272.19%-4.04M	---1.4M	---746K	---624K
Cash from discontinued financing activities
Financing cash flow	231,263.24%157.33M	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M	-68,200.00%-683K	---624K
Net cash flow
Beginning cash position	-72.62%55.07M	1.29%201.12M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	436.97%198.55M	-69.38%61.44M	-51.48%105.74M	--177.37M
Current changes in cash	197.10%52.59M	-5,780.51%-146.05M	-101.71%-2.39M	-72.98%-76.62M	82.01%-12.89M	-155.80%-54.16M	-98.41%2.57M	6,691.46%139.67M	-156.87%-44.29M	---71.64M
End cash Position	-26.74%107.66M	-72.62%55.07M	-72.62%55.07M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	1.29%201.12M	-69.38%61.44M	--105.74M
Free cash flow	-60.77%-70.03M	-17.72%-174.14M	-28.65%-45.7M	-20.60%-42.08M	-71.02%-42.8M	17.00%-43.56M	-286.91%-147.92M	-161.82%-35.53M	-205.24%-34.89M	---25.03M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall